Doxa AB

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005624756
SEK
0.40
0.01 (2.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Doxa AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-207.00
-1,723.00
291.00
-39.00
76.00
-13.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
511.00
-7.00
-6.00
-1.00
14.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
266.00
-63.00
-37.00
-38.00
-18.00
-13.00
Cash Flow from Investing Activities
292.00
-785.00
-205.00
-267.00
-392.00
-1.00
Cash Flow from Financing Activities
-540.00
807.00
294.00
350.00
422.00
14.00
Net Cash Inflow / Outflow
17.00
-41.00
51.00
44.00
10.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Doxa AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-207.6
-194.545
-13.00
-6.71%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
511
-22.621
533.00
2358.96%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
266.1
-39.114
305.00
780.32%
Cash Flow from Investing Activities
292.1
-117.196
409.00
349.24%
Cash Flow from Financing Activities
-540.6
268.986
-808.00
-300.98%
Net Cash Inflow / Outflow
17.6
112.41
-95.00
-84.34%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-0.265
0.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 521.04% vs -67.20% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
266.10
-63.20
521.04%